304 related articles for article (PubMed ID: 19381014)
1. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
Hyman MC; Petrovic-Djergovic D; Visovatti SH; Liao H; Yanamadala S; Bouïs D; Su EJ; Lawrence DA; Broekman MJ; Marcus AJ; Pinsky DJ
J Clin Invest; 2009 May; 119(5):1136-49. PubMed ID: 19381014
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
3. Disordered cellular migration and angiogenesis in cd39-null mice.
Goepfert C; Sundberg C; Sévigny J; Enjyoji K; Hoshi T; Csizmadia E; Robson S
Circulation; 2001 Dec; 104(25):3109-15. PubMed ID: 11748109
[TBL] [Abstract][Full Text] [Related]
4. Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.
Anyanwu AC; Kanthi Y; Fukase K; Liao H; Mimura T; Desch KC; Gruca M; Kaskar S; Sheikh-Aden H; Chi L; Zhao R; Yadav V; Wakefield TW; Hyman MC; Pinsky DJ
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):e118-e129. PubMed ID: 30816804
[TBL] [Abstract][Full Text] [Related]
5. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
Atkinson B; Dwyer K; Enjyoji K; Robson SC
Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
7. Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.
Baek AE; Sutton NR; Petrovic-Djergovic D; Liao H; Ray JJ; Park J; Kanthi Y; Pinsky DJ
Circulation; 2017 Jun; 135(24):2389-2402. PubMed ID: 28377485
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
9. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration.
Färber K; Markworth S; Pannasch U; Nolte C; Prinz V; Kronenberg G; Gertz K; Endres M; Bechmann I; Enjyoji K; Robson SC; Kettenmann H
Glia; 2008 Feb; 56(3):331-41. PubMed ID: 18098126
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.
Pinsky DJ; Broekman MJ; Peschon JJ; Stocking KL; Fujita T; Ramasamy R; Connolly ES; Huang J; Kiss S; Zhang Y; Choudhri TF; McTaggart RA; Liao H; Drosopoulos JH; Price VL; Marcus AJ; Maliszewski CR
J Clin Invest; 2002 Apr; 109(8):1031-40. PubMed ID: 11956240
[TBL] [Abstract][Full Text] [Related]
11. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
13. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
14. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
15. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
16. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
18. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
19. The impact of purinergic signaling on renal ischemia-reperfusion injury.
Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
[TBL] [Abstract][Full Text] [Related]
20. Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion.
Ben Yebdri F; Kukulski F; Tremblay A; Sévigny J
Eur J Immunol; 2009 Oct; 39(10):2885-94. PubMed ID: 19735076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
